[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EA200801023A1 - Применение фенофибрата или его производного для предотвращения диабетической ретинопатии - Google Patents

Применение фенофибрата или его производного для предотвращения диабетической ретинопатии

Info

Publication number
EA200801023A1
EA200801023A1 EA200801023A EA200801023A EA200801023A1 EA 200801023 A1 EA200801023 A1 EA 200801023A1 EA 200801023 A EA200801023 A EA 200801023A EA 200801023 A EA200801023 A EA 200801023A EA 200801023 A1 EA200801023 A1 EA 200801023A1
Authority
EA
Eurasian Patent Office
Prior art keywords
derivative
phenophibrate
application
diabetic retinopathy
prevent diabetic
Prior art date
Application number
EA200801023A
Other languages
English (en)
Other versions
EA014755B1 (ru
Inventor
Жан-Клод Анске
Энтони Кич
Original Assignee
Лабораториз Фурнье С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36130110&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200801023(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Лабораториз Фурнье С.А. filed Critical Лабораториз Фурнье С.А.
Publication of EA200801023A1 publication Critical patent/EA200801023A1/ru
Publication of EA014755B1 publication Critical patent/EA014755B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Данное изобретение относится к применению фенофибрата или его производного в изготовлении лекарства для предупреждения и/или лечения ретинопатии.
EA200801023A 2005-11-10 2006-11-10 Применение фенофибрата или его производного для предотвращения диабетической ретинопатии EA014755B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05292388A EP1785133A1 (en) 2005-11-10 2005-11-10 Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy
PCT/EP2006/068352 WO2007054566A2 (en) 2005-11-10 2006-11-10 Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy

Publications (2)

Publication Number Publication Date
EA200801023A1 true EA200801023A1 (ru) 2008-10-30
EA014755B1 EA014755B1 (ru) 2011-02-28

Family

ID=36130110

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801023A EA014755B1 (ru) 2005-11-10 2006-11-10 Применение фенофибрата или его производного для предотвращения диабетической ретинопатии

Country Status (18)

Country Link
US (1) US20090170939A1 (ru)
EP (3) EP1785133A1 (ru)
JP (1) JP5171635B2 (ru)
KR (1) KR20080074877A (ru)
CN (2) CN101304742A (ru)
AU (1) AU2006313711B2 (ru)
BR (1) BRPI0618283A2 (ru)
CA (1) CA2628508C (ru)
EA (1) EA014755B1 (ru)
ES (2) ES2605025T3 (ru)
HU (2) HUE030936T2 (ru)
IL (1) IL191208A (ru)
LT (1) LT3167882T (ru)
PL (2) PL1954261T3 (ru)
PT (2) PT3167882T (ru)
SI (1) SI3167882T1 (ru)
UA (1) UA99093C2 (ru)
WO (1) WO2007054566A2 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102304103A (zh) * 2011-06-03 2012-01-04 郑州泰基鸿诺药物科技有限公司 一种非诺贝特酸盐、制备方法、药物组合物及应用
CA2928702A1 (en) * 2013-10-25 2015-04-30 Children's Medical Center Corporation Methods of treating or preventing vascular diseases of the retina

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2494112B1 (ru) 1980-11-19 1986-01-10 Laruelle Claude
FR2602423B1 (fr) 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
FR2627696B1 (fr) 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
CA2052014A1 (en) * 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
SI9500173B (sl) 1995-05-19 2002-02-28 Lek, Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
DE19608750A1 (de) 1996-03-06 1997-09-11 Durachemie Gmbh & Co Kg Verfahren zur Herstellung von Fenofibrat-Präparaten
FR2758459B1 (fr) 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US6465011B2 (en) 1999-05-29 2002-10-15 Abbott Laboratories Formulations comprising lipid-regulating agents
IL155173A0 (en) * 2000-10-12 2003-10-31 Nissan Chemical Ind Ltd Prophylactic and therapeutic agent for diabetic complications
WO2002034259A1 (en) * 2000-10-26 2002-05-02 Fournier Laboratories Ireland Limited Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
NZ527408A (en) 2001-02-22 2005-04-29 Skyepharma Canada Inc Hydroxymethylglutarylcoenzyme A (HMG CoA) reductase inhibitor (or a statin) and a fibrate in a single effective oral dosage form to treat dyslipidaemia and dyslipoproteinaemia
CN100577175C (zh) * 2001-04-04 2010-01-06 奥索-麦克尼尔药品公司 包括葡萄糖重吸收抑制剂和ppar调节剂的联合疗法
CA2505771A1 (en) * 2002-12-10 2004-06-24 Novartis Ag Combination of an dpp-iv inhibitor and a ppar-alpha compound
US7259186B2 (en) 2002-12-17 2007-08-21 Abbott Laboratories Salts of fenofibric acid and pharmaceutical formulations thereof
JP2007504285A (ja) * 2003-01-17 2007-03-01 メルク　エンド　カムパニー　インコーポレーテッド Ｎ−シクロヘキシルアミノカルボニルベンゼンスルホンアミド誘導体
CA2555316A1 (en) * 2004-02-09 2005-08-18 Aska Pharmaceutical Co., Ltd. Combined pharmaceutical composition

Also Published As

Publication number Publication date
PT1954261T (pt) 2016-11-29
WO2007054566A2 (en) 2007-05-18
CA2628508A1 (en) 2007-05-18
EP1785133A1 (en) 2007-05-16
IL191208A (en) 2017-08-31
CN101304742A (zh) 2008-11-12
WO2007054566A3 (en) 2007-08-23
JP5171635B2 (ja) 2013-03-27
SI3167882T1 (sl) 2020-09-30
ES2605025T3 (es) 2017-03-10
BRPI0618283A2 (pt) 2012-02-28
EP3167882A1 (en) 2017-05-17
AU2006313711A9 (en) 2021-04-01
EA014755B1 (ru) 2011-02-28
KR20080074877A (ko) 2008-08-13
HUE030936T2 (en) 2017-06-28
AU2006313711B2 (en) 2012-02-23
AU2006313711A1 (en) 2007-05-18
LT3167882T (lt) 2020-07-27
IL191208A0 (en) 2009-08-03
CA2628508C (en) 2013-11-12
JP2009515856A (ja) 2009-04-16
HUE050045T2 (hu) 2020-11-30
PL3167882T3 (pl) 2020-11-16
EP3167882B1 (en) 2020-04-08
PT3167882T (pt) 2020-07-13
UA99093C2 (ru) 2012-07-25
US20090170939A1 (en) 2009-07-02
EP1954261A2 (en) 2008-08-13
CN103417524A (zh) 2013-12-04
PL1954261T3 (pl) 2017-07-31
ES2805227T3 (es) 2021-02-11
EP1954261B1 (en) 2016-08-24

Similar Documents

Publication Publication Date Title
CY1120102T1 (el) Συνθεσεις και μεθοδοι για μειωση τριγλυκεριδιων χωρις αυξηση επιπεδων ldl-c σε ενα υποκειμενο επι ταυτοχρονης θεραπειας στατινης
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
EA201170149A1 (ru) Новые аналоги инсулина пролонгированной активности
EA200870019A1 (ru) Лактамовые соединения и способы их применения
CY1112320T1 (el) Τιτλοδοτηση της ταπενταδολης
MX2007010560A (es) Roflumilast para el tratamiento de diabetes mellitus.
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA200900392A1 (ru) Комбинированное лечение сахарного диабета
EA200702358A1 (ru) Комбинация ингибитора pde4 и производного тетрагидробиоптерина
EA200601746A1 (ru) Применение ротиготина для лечения и предупреждения синдрома "паркинсонизм-плюс"
ATE540690T1 (de) Insulinkombinationen
EA201101117A1 (ru) Ингибиторы дпп-4 для лечения диабета у детей
CL2007003523A1 (es) Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad de pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso en el tratamiento profilactico o terapeutico del cancer
EA200701820A1 (ru) Применение диосметиновых соединений при лечении и профилактике тромботических патологий
ATE502633T1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
EA201300522A1 (ru) Фармацевтические комбинации для лечения метаболических нарушений
DE602007010664D1 (de) P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
EA200601777A1 (ru) Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии
EA200801244A1 (ru) Применение sdf-1 для лечения и/или профилактики неврологических заболеваний
CL2007003038A1 (es) Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
CY1115194T1 (el) Χρηση της μακρας πεντραξινης ptx3 για την προληψη ή θεραπεια ιικων ασθενειων
NO20076405L (no) Anvendelse av 24-nor-UDCA